Stocksigma LogoStocksigma Logo

Kilitch Drugs Divests Ethiopian Arm for $14 Million to Fund Expansion

Kilitch Drugs (India) announced on 23rd Oct'26 that it will divest its entire stake in Ethiopian subsidiary Kilitch Estro Biotech PLC to state-owned

Kilitch Drugs Divests Ethiopian Arm for $14 Million to Fund Expansion

Kilitch Drugs India Ltd 路 Press Release 路 23 Oct 2026, 8:45 pm

Kilitch Drugs Divests Ethiopian Arm for $14 Million to Fund Expansion Kilitch Drugs (India) announced on 23rd Oct'26 that it will divest its entire stake in Ethiopian subsidiary Kilitch Estro Biotech PLC to state-owned HarmeeCare Pharmaceuticals for US$14 million, targeted for completion by 31st Jan'27. The company will retain a commercial presence in Ethiopia via a long-term supply and technical services pact. Net proceeds will fund debt reduction and the phased expansion of its Pen, Maharashtra facility for injectables, ophthalmic drops, and GLP-1 therapies targeting regulated export markets under EU GMP and PIC/S standards.

Original exchange filing (PDF)

More announcements from Kilitch Drugs India Ltd

All Kilitch Drugs India Ltd announcements